Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Minoxidil can cause scalp comedones and acne.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Faulty LEF1 activation causes faster skin cell differentiation in premature aging syndrome.

Hutchinson-Gilford Progeria Syndrome causes rapid aging from a genetic mutation, with no cure but ongoing research into potential treatments.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Early NAS level changes affect alcohol consumption vulnerability.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Azathioprine may be an effective treatment for severe hair loss.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Innovative methods are reducing animal testing and improving biomedical research.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.